The efficacy of HCV eradication with direct-acting antivirals on patients with cirrhosis

The efficacy of HCV eradication with direct-acting antivirals on patients with cirrhosis - The efficacy of HCV clearance

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039580

Enrollment

Registered

2020-02-24

Start date

2019-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCV-related cirrhosis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HCV realted cirrhosis

Exclusion criteria

Exclusion criteria: viable HCC

Design outcomes

Primary

Measure	Time frame
Portal hemodynamic change	—

Secondary

Measure	Time frame
Change of liver function/ fibrosis/inflammation/protein expression/gut microbiome	—

Countries

Japan

Contacts

Public ContactTakayuki Kondo

Chiba University Graduate School of Medicine Department of Gastroenterology

takakon@chiba-u.jp0432262083

Outcome results